Rare diseases
Investigational molecules
Locations
Eiveniu G. 2, Kauno M. Sav., 50161 Kaunas, Lithuania
Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos in Kaunas, Lithuania specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Hidradenitis, Non-small cell lung cancer, and other specialisations. This site conducts important research.
At Lietuvos sveikatos mokslu universiteto ligonine Kauno klinikos, investigators are evaluating innovative treatments for a broad spectrum of cancers and blood disorders, with the goal of extending survival and preserving quality of life.
These trials focus on testing targeted agents, immunotherapies, and combination regimens to assess safety and effectiveness.
Researchers conduct clinical trials on heart disease, hypertension, and metabolic conditions, aiming to lower cardiovascular risk and protect kidney function.
The studies evaluate whether new medications can reduce heart attacks, strokes, or progression of renal impairment.
The department explores immune‑mediated conditions, seeking durable remission while minimizing adverse effects.
Trials often compare novel biologics or small molecules with standard care to determine efficacy and safety.
Clinical research targets disorders of the nervous system, focusing on disease‑modifying strategies and symptom control.
These studies assess long‑term safety of disease‑modifying therapies and their impact on disability progression.
The site evaluates therapies for lung infections and chronic respiratory illnesses, aiming to reduce exacerbations and improve pulmonary function.
Research includes antimicrobial agents and anti‑inflammatory drugs to shorten hospital stays and prevent complications.
Studies address both common and severe skin conditions, testing innovative biologics and small‑molecule inhibitors.
The aim is to achieve rapid symptom relief and durable skin clearance with improved safety profiles.
Research includes growth disorders in children, evaluating hormone therapies to support normal development.
Trials compare weekly versus daily growth hormone regimens to determine optimal height velocity and safety.
Clinical trials currently enrolling participants at this site.
Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
LithuaniaLithuaniaA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
LithuaniaA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
LithuaniaA study of duvakitug for patients with moderately to severely active ulcerative colitis to see if it works and is safe as maintenance therapy
LithuaniaA study testing duvakitug for patients with moderately to severely active ulcerative colitis
LithuaniaStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
LithuaniaStudy of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease
LithuaniaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
LithuaniaStudy of Elafibranor for Adults with Primary Biliary Cholangitis
LithuaniaA Phase 3 Study of Elritercept Versus Epoetin Alfa in ESA‑Naïve Adults with Lower‑Risk Myelodysplastic Syndrome Requiring Red Blood Cell Transfusions
LithuaniaStudy on JX10 for Improving Outcomes in Patients with Acute Ischemic Stroke
LithuaniaGet verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
